R Street Institute Senior Fellow Adam Thierer told FOX Business that to “unlock” the potential of mixed-reality technology for healthcare purposes in the U.S., the FDA “will need to streamline how it approves digital devices that have potential medical applications.”

“While the FDA has been taking steps in recent years to change how it treats digital health technologies, it’s still a complex and slow-moving process that often delays important inventions,” he said.